Lisata Therapeutics, Inc. (LSTA)
5.01
-0.01
(-0.20%)
USD |
NASDAQ |
Mar 25, 16:00
Lisata Therapeutics Free Cash Flow : -15.98M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Penumbra, Inc. | 174.93M |
| Protalix Biotherapeutics, Inc. | -13.63M |
| PAVmed, Inc. | -3.582M |
| Agenus, Inc. | -77.20M |
| Curis, Inc. | -27.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.249M |
| Cash from Financing (Quarterly) | 0.205M |
| Free Cash Flow Per Share (Quarterly) | -0.3678 |
| Free Cash Flow to Equity (Quarterly) | -3.249M |
| Free Cash Flow to Firm (Quarterly) | -3.249M |
| Free Cash Flow Yield | -36.68% |